Evaluation of the Safety, Tolerability and Pharmacokinetics of AH-001 Following Topical Single and Multiple Ascending Dose Administration
Clinical trial NCT06927960 · COMPLETED
Trial details
- NCT number
- NCT06927960
- Sponsor
- AnHorn Medicines Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-24
- Primary completion
- 2025-07-16
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.